PhotoMedex, Inc. to Present at the 15thAnnual Needham Growth Conference
MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)-- PhotoMedex, Inc. (NasdaqGS: PHMD) today announced that Dennis McGrath, president and chief financial officer, will present at the 15th Annual Needham Growth Conference on Thursday, January 17th at 2:10 p.m. Eastern Time. The presentation will provide a corporate overview and a discussion of the Company's growth strategy. The conference will be held at New York Palace Hotel, 455 Madison Avenue, New York.
Management will be available for one-on-one meetings with the investment community during the conference. Please contact Needham conference organizers if you would like to arrange a meeting.
Interested parties can access the audio webcast with slide presentation at www.photomedex.com. An archived presentation will be available for 90 days.
PhotoMedex is a global skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. The company provides proprietary products and services that address skin diseases and conditions including psoriasis, vitiligo, acne, actinic keratosis (a precursor to certain types of skin cancer) and photo damage. Its experience in the physician market provides the platform to expand its skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. As a result of its December 2011 merger with Radiancy Inc., PhotoMedex has added a range of home-use devices under the no!no!™ brand, for various indications including hair removal, acne treatment and skin rejuvenation. The company also offers a professional product line for acne clearance, skin tightening, psoriasis care and hair removal sold to physician clinics and spas.
KEYWORDS: United States North America New York Pennsylvania
The article PhotoMedex, Inc. to Present at the 15th Annual Needham Growth Conference originally appeared on Fool.com.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.